A hypertensive disorder that develops during pregnancy.
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 7, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 7, 2026
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 7, 2026
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning hypertension, pregnancy-induced
Updated Feb 3, 2026
Roche has entered a partnership with SangeneBio potentially worth up to $1.7 billion to enhance its RNA interference (RNAi) portfolio. This deal complements Roche's existing RNAi initiatives, including the hypertension candidate zilbesiran, which is partnered with Alnylam.
A CDC report reveals that two-thirds of U.S. adults with high cholesterol and half of those with high blood pressure are not receiving effective treatment, increasing their risk for heart attack and stroke. This highlights a critical gap in cardiovascular health management.
CDC will hold a media briefing to discuss new reports on the prevalence of high blood pressure and high cholesterol among U.S. adults. This event aims to raise awareness about these common health issues.